Clinical Trial Update: ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ctDNA-MRD guided consolidation therapy with toripalimab in stage IB-IIIA non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lung Cancer, Nonsmall Cell | Phase 2 | Status: RECRUITING